Universal Vision Biotechnology Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 21.94%

Universal Vision Biotechnology Co Ltd (3218) has an Asset Resilience Ratio of 21.94% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Universal Vision Biotechnology Co Ltd total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

NT$1.30 Billion
≈ $41.06 Million USD Cash + Short-term Investments

Total Assets

NT$5.94 Billion
≈ $187.12 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (2007–2024)

This chart shows how Universal Vision Biotechnology Co Ltd's Asset Resilience Ratio has changed over time. See 3218 net asset value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Universal Vision Biotechnology Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 3218 company net worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents NT$0.00 0%
Short-term Investments NT$1.30 Billion 21.94%
Total Liquid Assets NT$1.30 Billion 21.94%

Asset Resilience Insights

  • Good Liquidity Position: Universal Vision Biotechnology Co Ltd maintains a healthy 21.94% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Universal Vision Biotechnology Co Ltd Industry Peers by Asset Resilience Ratio

Compare Universal Vision Biotechnology Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Meinian Onehealth Healthcare Holdings Co Ltd
SHE:002044
Medical Care Facilities 0.04%
Sanbo Hospital Management Group Ltd. A
SHE:301293
Medical Care Facilities 1.40%
Bait Bakfar Ltd
TA:BKFR
Medical Care Facilities 6.18%
Pihlajalinna Oy
HE:PIHLIS
Medical Care Facilities 5.13%
Ramsay Health Care Ltd
AU:RHC
Medical Care Facilities 3.49%
Regis Healthcare Ltd
AU:REG
Medical Care Facilities 2.29%
Oceania Healthcare Ltd
AU:OCA
Medical Care Facilities 0.01%
Pacific Smiles Group Ltd
AU:PSQ
Medical Care Facilities 10.35%

Annual Asset Resilience Ratio for Universal Vision Biotechnology Co Ltd (2007–2024)

The table below shows the annual Asset Resilience Ratio data for Universal Vision Biotechnology Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 24.48% NT$1.41 Billion
≈ $44.44 Million
NT$5.76 Billion
≈ $181.56 Million
+13.21pp
2023-12-31 11.27% NT$578.36 Million
≈ $18.22 Million
NT$5.13 Billion
≈ $161.64 Million
-1.52pp
2022-12-31 12.80% NT$576.62 Million
≈ $18.17 Million
NT$4.51 Billion
≈ $141.96 Million
-0.69pp
2021-12-31 13.49% NT$505.81 Million
≈ $15.94 Million
NT$3.75 Billion
≈ $118.13 Million
-1.08pp
2020-12-31 14.57% NT$461.75 Million
≈ $14.55 Million
NT$3.17 Billion
≈ $99.85 Million
+1.77pp
2019-12-31 12.80% NT$338.97 Million
≈ $10.68 Million
NT$2.65 Billion
≈ $83.40 Million
-4.29pp
2018-12-31 17.09% NT$358.41 Million
≈ $11.29 Million
NT$2.10 Billion
≈ $66.06 Million
+7.87pp
2017-12-31 9.22% NT$184.89 Million
≈ $5.83 Million
NT$2.00 Billion
≈ $63.15 Million
-4.85pp
2016-12-31 14.07% NT$245.21 Million
≈ $7.73 Million
NT$1.74 Billion
≈ $54.91 Million
+8.04pp
2015-12-31 6.03% NT$113.99 Million
≈ $3.59 Million
NT$1.89 Billion
≈ $59.54 Million
-17.19pp
2014-12-31 23.22% NT$418.63 Million
≈ $13.19 Million
NT$1.80 Billion
≈ $56.79 Million
-1.52pp
2013-12-31 24.75% NT$337.88 Million
≈ $10.65 Million
NT$1.37 Billion
≈ $43.02 Million
+24.03pp
2012-12-31 0.72% NT$9.03 Million
≈ $284.53K
NT$1.26 Billion
≈ $39.59 Million
-1.31pp
2011-12-31 2.03% NT$28.10 Million
≈ $885.34K
NT$1.38 Billion
≈ $43.59 Million
+1.06pp
2009-12-31 0.98% NT$10.91 Million
≈ $343.60K
NT$1.12 Billion
≈ $35.22 Million
-0.04pp
2008-12-31 1.01% NT$11.03 Million
≈ $347.54K
NT$1.09 Billion
≈ $34.34 Million
-13.41pp
2007-12-31 14.42% NT$101.63 Million
≈ $3.20 Million
NT$704.59 Million
≈ $22.20 Million
--
pp = percentage points

About Universal Vision Biotechnology Co Ltd

TWO:3218 Taiwan Medical Care Facilities
Market Cap
$353.68 Million
NT$11.23 Billion TWD
Market Cap Rank
#14321 Global
#576 in Taiwan
Share Price
NT$132.50
Change (1 day)
-1.12%
52-Week Range
NT$123.50 - NT$218.50
All Time High
NT$655.60
About

Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. The company offers optical devices, glasses, lens, and vision aid products. It is also involved in leasing of medical devices. In addition, the company offers hospital management, optometric, and technical consultancy services, as well as provides medical and scientific prescription eyeglasses. Furt… Read more